Abstract
Background
Adequate treatment for extremely advanced endometrial cancer is unknown. The purpose of this study was to clarify the prognosis of patients with stage IVB endometrial carcinoma and the validity of treatment. Furthermore, we evaluated whether there was a connection between the prognosis and the site of metastasis.
Methods
The prognoses of 55 patients with stage IVB endometrial carcinoma were studied with reference to the initial treatment method and the metastatic site at the time of the initial treatment.
Results
The median survivals of the group of 35 patients who were initially treated with surgery and the group of 10 patients who underwent radiotherapy or chemotherapy as their initial treatment followed by surgery were 11.5 months and 9.5 months, respectively. The residual tumor diameter after surgery was precisely measured in 40 of these 45 patients. The prognosis was significantly better in the patients with a residual tumor diameter of less than 2 cm compared to those with a tumor diameter of 2 cm or greater, and the median survival periods in these two groups were 23.5 months and 11.5 months, respectively (P = 0.027). Furthermore, the prognosis of patients with lung metastasis was significantly better than that of patients with non-lung hematogenous metastasis; the median survival periods of these two groups were 18.5 months and 10.5 months, respectively (P = 0.014).
Conclusion
For operable patients, surgery as an initial treatment and reduction of the residual tumor size to less than 2 cm appeared to contribute to a better prognosis. In addition, conservative initial treatment and the presence of non-lung hematogenous metastasis were poor prognostic factors.
Similar content being viewed by others
References
Landis SH, Murray T, Bolden S, et al. (1999) Cancer statistics 1999. CA Cancer J Clin 49:8–31
Pecorrelli S, Creasman WT, Pettersson F, et al. (1998) FIGO annual report on the results of treatment in gynecologic cancer. J Epidemiol Biostat 3:35–62
Wolfson AH, Sightler SE, Markoe AM, et al. (1992) The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 45:142–146
Marino BD, Burke TW, Tornos C, et al. (1995) Staging laparotomy for endometrial carcinoma. Assessment of peritoneal spread. Gynecol Oncol 56:34–38
Vardi JR, Tadros GH, Anselmo MT, et al. (1992) The value of exploratory laparotomy in patients with endometrial carcinoma according to the new International Federation of Gynecology and Obstetrics staging. Obstet Gynecol 80:204–208
Goff BA, Goodman A, Muntz HG, et al. (1994) Surgical IV endometrial carcinoma: a study of 47 patients. Gynecol Oncol 52: 237–240
Chi DS, Welshinger M, Verkatraman RR (1997) The role of surgical cytoreduction in stage IV endometrial carcinoma. Gynecol Oncol 67:56–60
Bristow RE, Zerbe MJ, Rosenshein NB, et al. (2000) Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol Oncol 78:85–91
Kaplan EL, Meier P (1958) Non-parametric estimation for incomplete observations. J Am Stat Assoc 53:457–481
Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170
Snedecor GW, Cochran WG (1980) Statistical methods, 6th edn. Iowa State University Press, Ames, IA
Le TD, Yamada SD, Rutgers JL, et al. (1999) Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with taxol and carboplatin. Gynecol Oncol 73: 461–463
Compagnutta E, Giorda G, De Piero G, et al. (2004) Surgical treatment of recurrent endometrial carcinoma. Cancer 100:89–96
Greven K, Olds W (1987) Radiotherapy in the management of endometrial carcinoma with cervical involvement. Cancer 60: 1737–1740
Grigsby PW, Pertz CA, Camel HM, et al. (1985) Stage II carcinoma of the endometrium: results of therapy and prognostic factors. Int J Radiat Oncol Biol Phys 11:1915–1923
NCCN practice guidelines in oncology v.l.2005. Uterine cancers. http://www.nccn.org/professionals/physician
Landgren RC, Fletcher GH, Delclos L, et al. (1976) Irradiation of endometrial cancer in patients with medical contraindication to surgery or with unresectable lesions. AJR Am J Roentgenol 126: 148–154
Pliskow S, Penalver M, Averette HE (1990) Stage III and IV endometrial carcinoma: a review of 41 cases. Gynecol Oncol 38:210–215
Aalders JG, Aberler V, Kolstad P (1984) Stage IV endometrial carcinoma: a clinical and histological study of 83 patients. Gynecol Oncol 17:75–84
Behbakht K, Yorden EL, Casey C, et al. (1994) Prognosis indicators of survival in advanced endometrial cancer. Gynecol Oncol 55:363–367
Author information
Authors and Affiliations
Corresponding author
Additional information
R. Numazaki and E. Miyagi contributed equally to this study.
About this article
Cite this article
Numazaki, R., Miyagi, E., Konnai, K. et al. Analysis of stage IVB endometrial carcinoma patients with distant metastasis: a review of prognoses in 55 patients. Int J Clin Oncol 14, 344–350 (2009). https://doi.org/10.1007/s10147-009-0878-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-009-0878-3